SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-062688
Filing Date
2011-03-11
Accepted
2011-03-10 21:16:45
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1730663
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2205
3 CONSENT OF CHERRY, BEKAERT & HOLLAND, L.L.P. dex231.htm EX-23.1 1811
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9264
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9221
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3137
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3314
8 GRAPHIC g122654g95u87.jpg GRAPHIC 72339
  Complete submission text file 0001193125-11-062688.txt   1860578
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31361 | Film No.: 11680057
SIC: 2834 Pharmaceutical Preparations